Search - tctmd.com

Displaying 161 - 180 of 375

Sort: Relevancy | Date

TCT 698: Treatment of Severe Symptomatic Carotid Artery Stenosis in a Medically Complex Patient With High Surgical Risk Utilizing the MOMA Proximal Protection Device

Presentation TCT 2020

TCT 698: Treatment of Severe Symptomatic Carotid Artery Stenosis in a Medically Complex Patient With High Surgical Risk Utilizing the MOMA Proximal Protection Device

Presenter: Marina Iskandir

October 14, 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

October 09, 2020

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

News Daily News

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

September 17, 2020

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

News Daily News

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

August 21, 2020

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

News Daily News

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

June 29, 2020

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

News Daily News

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

June 18, 2020

Recovered Paclitaxel PAD Data Shift the Mortality Picture

News Daily News

Recovered Paclitaxel PAD Data Shift the Mortality Picture

May 14, 2020

Skipping tPA Before Stroke Thrombectomy May Be Okay: DIRECT-MT

News Daily News

Skipping tPA Before Stroke Thrombectomy May Be Okay: DIRECT-MT

May 11, 2020

News Industry News

Thrombolex Bashir® Endovascular Catheter First-In-Human (FIH) Trial for Acute Pulmonary Embolism Confirms Early Safety and Feasibility and Impressive Reduction of Clot Burden

March 05, 2020

Industry Payments to Vascular Neurologists Jump in the Thrombectomy Era

News Conference News ISC 2020

Industry Payments to Vascular Neurologists Jump in the Thrombectomy Era

February 29, 2020

SKIP Questions Need for IV Thrombolysis Before Stroke Thrombectomy

News Conference News ISC 2020

SKIP Questions Need for IV Thrombolysis Before Stroke Thrombectomy

February 25, 2020

Another Neuroprotective Agent Fails in Acute Stroke . . . Or Does It?

News Conference News ISC 2020

Another Neuroprotective Agent Fails in Acute Stroke . . . Or Does It?

February 21, 2020

EVAR—but Not Surgical AAA Repair—is Riskier Long-term for Women

News Daily News

EVAR—but Not Surgical AAA Repair—Is Riskier Long-term for Women

February 18, 2020

PE for Surgeons: Be Active Participants in Team-Based Care, Experts Urge

News Conference News STS 2020

PE for Surgeons: Be Active Participants in Team-Based Care, Experts Urge

Yael L. Maxwell

February 03, 2020

DCBs Show Consistent Long-term Benefits in Complex Fem-Pop Patient Subsets

News Conference News LINC 2020

DCBs Show Consistent Long-term Benefits in Complex Fem-Pop Patient Subsets

January 30, 2020

Lutonix BTK Studies: Below-the-Knee Challenges Linger

News Conference News LINC 2020

Lutonix BTK Studies: Below-the-Knee Challenges Linger

January 29, 2020

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

News Conference News LINC 2020

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

January 28, 2020

Leaving the Hospital Nest? OBL Advice From Those Who’ve Done It

News Conference News ISET 2020

Leaving the Hospital Nest? OBL Advice From Those Who’ve Done It

January 28, 2020

News Conference News ISET 2020

FDA’s First Take on New Paclitaxel Concerns in CLI

January 24, 2020

Venous Stents: Long-term Follow-up Plus a New Contender

News Conference News ISET 2020

Venous Stents: Long-term Follow-up Plus a New Contender

January 24, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.